BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11327084)

  • 21. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process.
    Agostini C; Trentin L; Perin A; Facco M; Siviero M; Piazza F; Basso U; Adami F; Zambello R; Semenzato G
    Am J Physiol; 1999 Aug; 277(2):L240-50. PubMed ID: 10444517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cells in human periodontal disease.
    Gemmell E; Carter CL; Seymour GJ
    J Dent Res; 2004 May; 83(5):384-7. PubMed ID: 15111629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
    J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
    Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
    Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines in human periodontal disease tissues.
    Gemmell E; Carter CL; Seymour GJ
    Clin Exp Immunol; 2001 Jul; 125(1):134-41. PubMed ID: 11472436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
    Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
    J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
    Slavik JM; Hutchcroft JE; Bierer BE
    Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-surface proteoglycan expression by lymphocytes from peripheral blood and gingiva in health and periodontal disease.
    Manakil JF; Sugerman PB; Li H; Seymour GJ; Bartold PM
    J Dent Res; 2001 Aug; 80(8):1704-10. PubMed ID: 11669479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K; Dalakas MC
    Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma delta T lymphocytes in human periodontal disease tissue.
    Gemmell E; Seymour GJ
    J Periodontol; 1995 Sep; 66(9):780-5. PubMed ID: 7500244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
    Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
    Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adhesion molecule expression in chronic inflammatory periodontal disease tissue.
    Gemmell E; Walsh LJ; Savage NW; Seymour GJ
    J Periodontal Res; 1994 Jan; 29(1):46-53. PubMed ID: 7509385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.